Mercados españoles cerrados en 6 hrs 5 min

Olema Pharmaceuticals, Inc. (OLMA)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
11,73-0,15 (-1,26%)
Al cierre: 04:00PM EDT
11,98 +0,25 (+2,13%)
Después del cierre: 07:46PM EDT
Accionistas principales
Lista de personas con información privilegiada

Transacciones de accionistas miembros de la empresa

Divisa en USD
Compras de personas con información privilegiada de los 6 últimos mesesAccionesTrans
Compras93.1604
Ventas1.320.0008
Cuotas netas adquiridas (vendidas)-1.226.84012
Acciones de persona con información privilegiada totales2,13MN/A
% de acciones netas adquiridas (vendidas)-36,50%N/A
Compras institucionales netas del trimestre anterior al último trimestreAcciones
Cuotas netas adquiridas (vendidas)N/A
% de cambio en la posesión de acciones institucionalesN/A

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

Persona con información privilegiadaTransacciónTipoValorFechaAcciones

HARMON CYRUS
Director

Sale at price 9.41 - 12.33 per share.Directo257.45004 jun 202425.000

GRAHAM G. WALMSLEY
Director

Sale at price 14.85 per share.Indirecto17.448.75004 jun 20241.175.000

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 4.87 per share.Directo46.07024 may 20249.460

HARMON CYRUS
Director

Sale at price 10.92 per share.Directo54.60006 may 20245.000

HARMON CYRUS
Director

Sale at price 9.51 per share.Directo142.65030 abr 202415.000

HARMON CYRUS
Director

Sale at price 10.97 per share.Directo219.40028 mar 202420.000

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 4.87 per share.Directo66.71918 mar 202413.700

HARMON CYRUS
Director

Sale at price 12.41 - 13.00 per share.Directo310.30929 feb 202425.000

HARMON CYRUS
Director

Sale at price 12.23 - 15.56 per share.Directo383.55001 feb 202430.000

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 7.02 per share.Directo140.40025 ene 202420.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Conversion of Exercise of derivative security at price 7.02 per share.Directo351.00012 ene 202450.000

HARMON CYRUS
Director

Sale at price 13.30 - 14.10 per share.Directo334.50029 dic 202325.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Conversion of Exercise of derivative security at price 7.02 per share.Directo70.20012 dic 202310.000

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 7.02 per share.Directo20.35811 dic 20232.900

ZOJWALLA NASEEM M.D.
Officer

Conversion of Exercise of derivative security at price 7.02 per share.Directo91.96206 dic 202313.100

PARADIGM BIOCAPITAL ADVISORS LP
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 11.60 per share.Indirecto1.160.00006 dic 2023100.000

WALMSLEY GRAHAM G
Director

Purchase at price 9.84 - 14.95 per share.Indirecto6.871.27905 dic 2023640.000

HARMON CYRUS
Director

Sale at price 12.57 per share.Directo314.25030 nov 202325.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Sale at price 13.89 - 15.27 per share.Directo269.65622 nov 202318.742

HARMON CYRUS
Director

Sale at price 13.90 - 14.86 per share.Directo117.74022 nov 20238.181

MYLES DAVID C PH.D.
Officer

Sale at price 13.89 - 15.32 per share.Directo196.23322 nov 202313.629

BOHEN SEAN
Chief Executive Officer

Sale at price 13.90 - 15.29 per share.Directo824.13422 nov 202357.225

ZOJWALLA NASEEM M.D.
Officer

Sale at price 13.89 - 15.33 per share.Directo209.29622 nov 202314.556

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Stock Award(Grant) at price 0.00 per share.Directo020 nov 202336.750

HARMON CYRUS
Director

Stock Award(Grant) at price 0.00 per share.Directo020 nov 202315.750

MYLES DAVID C PH.D.
Officer

Stock Award(Grant) at price 0.00 per share.Directo020 nov 202326.250

BOHEN SEAN
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Directo020 nov 2023110.250

ZOJWALLA NASEEM M.D.
Officer

Stock Award(Grant) at price 0.00 per share.Directo020 nov 202328.000

MYLES DAVID C PH.D.
Officer

Sale at price 17.61 per share.Directo3.52208 nov 2023200

MYLES DAVID C PH.D.
Officer

Sale at price 15.02 - 17.51 per share.Directo160.80603 nov 202310.541

HARMON CYRUS
Director

Sale at price 12.05 - 15.64 per share.Directo379.45002 nov 202330.000

HARMON CYRUS
Director

Sale at price 12.41 per share.Directo310.25029 sept 202325.000

MYLES DAVID C PH.D.
Officer

Sale at price 12.67 per share.Directo253.40019 sept 202320.000

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 9.84 per share.Indirecto14.818.37112 sept 20231.505.932

HARMON CYRUS
Director

Sale at price 9.36 - 11.62 per share.Directo256.60005 sept 202325.000

HARMON CYRUS
Director

Sale at price 10.14 per share.Directo152.10016 ago 202315.000

HARMON CYRUS
Director

Sale at price 10.14 per share.Directo152.10016 ago 202315.000

HARMON CYRUS
Director

Sale at price 6.30 per share.Directo63.00008 jun 202310.000

HARMON CYRUS
Director

Sale at price 6.04 - 6.29 per share.Directo61.70006 jun 202310.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Purchase at price 3.29 per share.Directo32.90006 abr 202310.000

BOHEN SEAN
Chief Executive Officer

Stock Award(Grant) at price 0.00 per share.Directo021 sept 202220.000

BOHEN SEAN
Chief Executive Officer

Purchase at price 2.97 per share.Directo59.40021 sept 202220.000

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Purchase at price 3.47 per share.Directo69.40002 sept 202220.000

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 4.03 per share.Indirecto806.90010 jun 2022200.000

HORN KINNEY
Officer

Sale at price 4.75 per share.Directo24.95210 mar 20225.253

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.84210 mar 20225.253

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.83810 feb 20225.251

HORN KINNEY
Officer

Sale at price 6.85 per share.Directo35.96910 ene 20225.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.83810 ene 20225.251

MYLES DAVID C PH.D.
Officer

Sale at price 10.30 per share.Directo103.00010 dic 202110.000

HORN KINNEY
Officer

Sale at price 10.39 per share.Directo54.55810 dic 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.83810 dic 20215.251

BVF PARTNERS L P
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 9.39 per share.Indirecto6.945.77030 nov 2021739.675

HARMON CYRUS
Chief Technology Officer

Sale at price 24.76 per share.Directo9.90429 nov 2021400

HORN KINNEY
Officer

Sale at price 26.88 per share.Directo743.71610 nov 202127.668

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 - 19.00 per share.Directo436.76110 nov 202127.668

HARMON CYRUS
Chief Technology Officer

Sale at price 27.85 - 28.20 per share.Directo335.79419 oct 202112.000

BOHEN SEAN
Chief Executive Officer

Sale at price 30.42 - 31.17 per share.Directo152.36314 oct 20215.000

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Directo24.12014 oct 20215.000

HORN KINNEY
Officer

Sale at price 27.47 - 28.19 per share.Directo146.51011 oct 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.83811 oct 20215.251

BOHEN SEAN
Chief Executive Officer

Sale at price 30.07 per share.Directo32.62627 sept 20211.085

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Directo5.23427 sept 20211.085

HARMON CYRUS
Chief Technology Officer

Sale at price 26.30 per share.Directo315.60020 sept 202112.000

HORN KINNEY
Officer

Sale at price 29.38 per share.Directo154.27410 sept 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.83810 sept 20215.251

BOHEN SEAN
Chief Executive Officer

Sale at price 30.00 - 30.08 per share.Directo91.35308 sept 20213.044

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Directo14.68408 sept 20213.044

BOHEN SEAN
Chief Executive Officer

Sale at price 30.05 per share.Directo26.17401 sept 2021871

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Directo4.20201 sept 2021871

HARMON CYRUS
Chief Technology Officer

Sale at price 24.97 per share.Directo299.64019 ago 202112.000

HORN KINNEY
Officer

Sale at price 25.70 - 26.17 per share.Directo134.97910 ago 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.83810 ago 20215.251

HARMON CYRUS
Chief Technology Officer

Sale at price 24.83 - 25.63 per share.Directo301.25820 jul 202112.000

HORN KINNEY
Officer

Sale at price 26.33 - 27.00 per share.Directo139.19112 jul 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.83812 jul 20215.251

HARMON CYRUS
Chief Technology Officer

Sale at price 24.54 - 26.30 per share.Directo297.62618 jun 202112.000

HORN KINNEY
Officer

Sale at price 28.30 - 29.97 per share.Directo156.07110 jun 20215.251

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo10.83810 jun 20215.251

HORN KINNEY
Officer

Sale at price 24.03 - 24.81 per share.Directo1.394.76918 may 202157.763

HORN KINNEY
Officer

Conversion of Exercise of derivative security at price 2.06 per share.Directo119.22318 may 202157.763

RAPPAPORT ANDREW S
Director

Indirecto23 nov 2020448.556

MCCORMICK FRANK
Director

Indirecto23 nov 2020219.217

CORMORANT ASSET MANAGEMENT ,L.P
Former

Purchase at price 52.78 per share.Indirecto22.431.50023 nov 2020425.000

CORMORANT ASSET MANAGEMENT ,L.P
Former

Indirecto23 nov 20202.845.544

WALMSLEY GRAHAM G
Director

Purchase at price 48.90 per share.Indirecto56.724.00023 nov 20201.160.000

WALMSLEY GRAHAM G
Director

Indirecto23 nov 20202.583.875

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN I L
Beneficial Owner of more than 10% of a Class of Security

Directo23 nov 20201.725.406

KUSHNER PETER J PH.D.
Officer

Directo23 nov 2020358.920

HARMON CYRUS
Chief Technology Officer

Indirecto23 nov 2020193.402

MYLES DAVID C PH.D.
Officer

Indirecto23 nov 2020167.677

BOHEN SEAN
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.82 per share.Directo249.15523 sept 202051.649

BUTITTA CYNTHIA M
Director

Conversion of Exercise of derivative security at price 4.41 per share.Directo369.55816 sept 202083.876

KOVACS SHANE WILLIAM CHARLES
Chief Operating Officer

Directo15 jun 2020358.680

KUSHNER PETER J PH.D.
Officer

Directo15 jun 2020143.472

HARMON CYRUS
Chief Technology Officer

Directo15 jun 2020143.472

MYLES DAVID C PH.D.
Officer

Directo15 jun 2020143.472